Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch

SAN DIEGO, Aug. 29, 2017 -- (Healthcare Sales & Marketing Network) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) ("Sorrento"), announced today that SCILEX Pharmaceuticals Inc. ("SCILEX"), a majority-owned subsidiary of Sorrento, resubm... Biopharmaceuticals, Drug Delivery, FDA Sorrento Therapeutics, SCILEX Pharmaceuticals, ZTlido, lidocaine patch
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news